Surgical Pathology of Colorectal Cancer

  • Carolyn C. Compton
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

From initial diagnosis through definitive treatment, pathologic evaluation plays a central role in the care of patients with colorectal cancer. The pathologic stage of a surgically resected colorectal carcinoma is widely recognized as the most accurate predictor of survival and it typically determines the appropriateness of adjuvant treatment as well. Numerous additional pathologic factors have been shown by multivariate analyses to have prognostic significance that is independent of stage, and these may help to further substratify tumors. In this chapter, the pathologic features of colorectal cancers that predict outcome after surgical resection and have direct bearing on patient care are reviewed.

Keywords

Colorectal Cancer Rectal Cancer Colorectal Carcinoma Circumferential Resection Margin Mucinous Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sherlock P and Winawer SJ. Are there markers for the risk of colorectal cancer? N. Engl. J. Med., 311 (1984) 118–119.PubMedCrossRefGoogle Scholar
  2. 2.
    Itzkowitz SH. Gastrointestinal adenomatous polyps. Semin. Gastrointest. Dis., 7 (1996) 105–116.PubMedGoogle Scholar
  3. 3.
    Muto T, Bussey HJR, and Morson BC. The evolution of cancer of the colon and rectum. Cancer, 36 (1975) 2251–2270.PubMedCrossRefGoogle Scholar
  4. 4.
    Jass JR. Malignant colorectal polyps. Gastroenterology, 109 (1995) 2034–2035.PubMedCrossRefGoogle Scholar
  5. 5.
    Morson BC, Whiteway JE, Jones EA, et al. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut, 25 (1984) 437–444.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolff WI and Shinya H. Definitive treatment of “malignant” polyps of the colon. Ann. Surg., 182 (1975) 516–525.PubMedCrossRefGoogle Scholar
  7. 7.
    Wilcox GM, Anderson PB, and Colacchio TA. Early invasive carcinoma in colonic polyps: a review of the literature with emphasis on the assessment of the risk of metastasis. Cancer, 57 (1986) 160–171.PubMedCrossRefGoogle Scholar
  8. 8.
    Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology, 108 (1995) 1657–1665.PubMedCrossRefGoogle Scholar
  9. 9.
    Cranley JP, Petras RE, Carey WD, et al. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology, 91 (1986) 419–427.PubMedGoogle Scholar
  10. 10.
    Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am. J. Surg. Pathol., 7 (1983) 613–623.PubMedCrossRefGoogle Scholar
  11. 11.
    Cooper HS. The role of the pathologist in the management of patients with endoscopically removed malignant colorectal polyps. Pathol. Annu., 23 (1988) 25–43.PubMedGoogle Scholar
  12. 12.
    Cooper HS, Deppisch LM, Kahn EI, et al. Pathology of the malignant colorectal polyp. Hum. Pathol., 29 (1998) 15–26.PubMedCrossRefGoogle Scholar
  13. 13.
    Cunningham KN, Mills LR, Schuman BM, et al. Long-term prognosis of well-differentiated adenocarcinoma in endoscopically removed colorectal adenomas. Dig. Dis. Sci., 39 (1994) 2034–2037.PubMedCrossRefGoogle Scholar
  14. 14.
    Haggitt RC, Glotzbach RE, Soffer EE, et al. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology, 89 (1985) 328–336.PubMedGoogle Scholar
  15. 15.
    Lipper S, Kahn LB, and Ackerman LV. The significance of microscopic invasive cancer in endoscopically removed polyps of the large bowel. A clinicopathologic study of 51 cases. Cancer, 52 (1983) 1691–1699.PubMedCrossRefGoogle Scholar
  16. 16.
    Kyzer S, Begin LR, Gordan PH, et al. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Cancer, 70 (1992) 2044–2050.PubMedCrossRefGoogle Scholar
  17. 17.
    Muller S, Chesner IM, Egan MJ, et al. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut, 30 (1989) 1385–1391.PubMedCrossRefGoogle Scholar
  18. 18.
    Volk EE, Goldblum JR, Petras RE, et al Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology, 109 (1995) 1801–1807.PubMedCrossRefGoogle Scholar
  19. 19.
    Coverlizza S, Risio M, Ferrari A, et al. Colorectal adenomas containing invasive carcinoma: pathologic assessment of lymph node metastatic potential. Cancer, 64 (1989) 1937–1947.PubMedCrossRefGoogle Scholar
  20. 20.
    Nivatvongs S and Goldberg SM. Management of patients who have polyps containing invasive carcinoma removed via colonoscope. Dis. Colon Rectum, 21 (1978) 8–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Nivatvongs S, Rojanasakul A, Reiman HM, et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis. Colon Rectum, 34 (1991) 323–328.PubMedCrossRefGoogle Scholar
  22. 22.
    Wilcox GM, Anderson PB, and Colacchio TA. Early invasive carcinoma in colonic polyps: a review of the literature with emphasis on the assessment of the risk of metastasis. Cancer, 57 (1986) 160–171.PubMedCrossRefGoogle Scholar
  23. 23.
    Wilcox GM and Beck JR. Early invasive cancer in adenomatous colonic polyps (“malignant polyps”). Evaluation of the therapeutic options by decision analysis. Gastroenterology, 92 (1987) 1159–1168.PubMedGoogle Scholar
  24. 24.
    Fleming ID, Cooper JS, Henson DE, et al. (eds.). AJCC Manual for Staging of Cancer. 5th ed. Philadelphia, Lippincott-Raven, 1997.Google Scholar
  25. 25.
    Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Terminology (ICAT). J. Gastroenterol. Hepatol., 6 (1991) 325–344.PubMedCrossRefGoogle Scholar
  26. 26.
    Wittekind C, Henson DE, Hutter RVP, Sobin LH, eds. TNM Supplement. A Commentary on Uniform Use. 2nd ed. Wiley-Liss, New York, 2001.Google Scholar
  27. 27.
    Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br. J. Surg., 72 (1985) 698–702.PubMedCrossRefGoogle Scholar
  28. 28.
    D’Eredita G, Serio G, Neri V, et al. A survival regression analysis of prognostic factors in colorectal cancer. Aust. NZ J. Surg., 66 (1996) 445–451.CrossRefGoogle Scholar
  29. 29.
    Frank R, Saclarides T, Leurgans S, et al. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann. Surg., 222 695–699.Google Scholar
  30. 30.
    Griffin M, Bergstralh E, Coffey R, et al. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer, 60 (1987) 2318–2324.PubMedCrossRefGoogle Scholar
  31. 31.
    Mulcahy HE, Skelly MM, Husain A, et al. Long-term outcome following curative surgery for malignant large bowel obstruction. Br. J. Surg., 83 (1996) 46–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Newland R, Dent O, Lyttle M, et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer, 73 (1994) 2076–2082.PubMedCrossRefGoogle Scholar
  33. 33.
    Roncucci L, Fante R, Losi L, et al. Survival for colon and rectal cancer in a population-based cancer registry. Fur. J. Cancer, 32A (1996) 295–302.Google Scholar
  34. 34.
    Takebayashi Y, Akiyama S, Yamada K, et al. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer, 78 (1996) 226–231.PubMedCrossRefGoogle Scholar
  35. 35.
    Crucitti F, Sofo L, Doglietto G, et al. Prognostic factors in colorectal cancer: current status and new trends. J. Surg. Oncol., 2 (1991) 76–82.CrossRefGoogle Scholar
  36. 36.
    Deans G, Heatley M, Anderson N, et al. Jass’ Classification revisited. J. Am. Coll. Surg., 179 (1994) 11–17.PubMedGoogle Scholar
  37. 37.
    Freedman L, Macaskill P, and Smith A. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet, II (1984) 733–736.CrossRefGoogle Scholar
  38. 38.
    Michelassi F, Ayala J, Balestracci T, et al. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann. Surg., 214 (1991) 11–18.PubMedGoogle Scholar
  39. 39.
    Michelassi F, Block GE, Vannucci L, et al. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann. Surg., 208 (1988) 379–387.PubMedCrossRefGoogle Scholar
  40. 40.
    Hobday TJ and Erlichman C. Colorectal cancer. In Prognostic Factors in Cancer. Gospodarowicz MK, Henson DE, Hutter RVP, O’Sullivan B, Sobin LH, Wittekind C, eds. Wiley-Liss, New York, 2001, pp. 311–332.Google Scholar
  41. 41.
    Compton CC. Updated protocol for the examination of specimens removed from patients with carcinomas of the colon and rectum excluding carcinoid tmors, lymphomas, sarcomas, and tumors of the vermiform appendix. A basis for checklists. Arch. Pathol. Lab. Med., 124 (2000) 1016–1025.PubMedGoogle Scholar
  42. 42.
    Hamilton SR, Rubio CA, Vogelstein B, et al. Carcinoma of the colon and rectum. In World Health Organization Classification of Tumours. Tumours of the Digestive System. IARC Press, Lyon France, 2000, pp. 101–119.Google Scholar
  43. 43.
    Carlon C, Fabris G, Arslan-Pagnini C, et al. Prognostic correlations of operable carcinoma of the rectum. Dis. Colon Rectum, 28 (1985) 47–50.PubMedCrossRefGoogle Scholar
  44. 44.
    Green J, Timmcke A, Mitchell W, et al. Mucinous carcinoma just another colon cancer? Dis. Colon Rectum, 36 (1993) 49–54.PubMedCrossRefGoogle Scholar
  45. 45.
    Hermanek P, Guggenmoos-Holzmann I, and Gall FP. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification. Dis. Colon Rectum, 32 (1989) 593–599.PubMedCrossRefGoogle Scholar
  46. 46.
    Jass J, Atkin W, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology, 10 (1986) 437–459.PubMedCrossRefGoogle Scholar
  47. 47.
    Jass J, Love S, and Northover J. A new prognostic classification of rectal cancer. Lancet, I (1987) 1303–1306.CrossRefGoogle Scholar
  48. 48.
    Robey-Cafferty SS, el-Naggar AK, Grignon DJ, et al. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. Mod. Pathol., 3 (1990) 261–266.PubMedGoogle Scholar
  49. 49.
    Spratt J and Spjut H. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer, 20 (1967) 1976–1985.PubMedCrossRefGoogle Scholar
  50. 50.
    Umpleby HC and Williamson RC. Carcinoma of the large bowel in the first four decades. Br. J. Surg., 71 (1984) 272–277.PubMedCrossRefGoogle Scholar
  51. 51.
    Jesserun J, Romero-Guadarrama M, and Manivel JC. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum. Pathol., 30 (1999) 843–848.CrossRefGoogle Scholar
  52. 52.
    Minsky B, Mies C, Rich T, et al. Colloid carcinoma of the colon and rectum. Cancer, 60 (1987) 3103–3112.PubMedCrossRefGoogle Scholar
  53. 53.
    Secco G, Fardelli R, Campora E, et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology, 51 (1994) 30–34.PubMedCrossRefGoogle Scholar
  54. 54.
    Symonds D and Vickery A. Mucinous carcinoma of the colon and rectum. Cancer, 37 (1976) 1891–1900.PubMedCrossRefGoogle Scholar
  55. 55.
    Heys S, Sherif A, Bagley J, et al. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br. J. Surg., 81 (1994) 685–688.PubMedCrossRefGoogle Scholar
  56. 56.
    Harrison J, Dean P, El-Zeky F, et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum. Pathol., 25 (1994) 498–505.PubMedCrossRefGoogle Scholar
  57. 57.
    Sasaki O, Atkin WS, and Jass JR. Mucinous carcinoma of the rectum. Histopathology, 11 (1987) 259–272.PubMedCrossRefGoogle Scholar
  58. 58.
    Shepherd N, Saraga E, Love S, et al. Prognostic factors in colonic cancer. Histopathology, 14 (1989) 613–620.PubMedCrossRefGoogle Scholar
  59. 59.
    Halvorsen T and Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J. Clin. Pathol., 42 (1989) 162–166.PubMedCrossRefGoogle Scholar
  60. 60.
    Öfner D, Riedmann B, Maier H, et al. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma-correlation with tumour stage and long-term survival. J. Pathol., 75 (1995) 441–448.CrossRefGoogle Scholar
  61. 61.
    Staren ED, Gould VE, Warren WH, et al. Neuroendocrine carcinomas of the colon and rectum: a clinico-pathologic correlation. Surgery, 104 (1988) 1080–1089.PubMedGoogle Scholar
  62. 62.
    DeBruine A, Wiggers T, Beek C, et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int. J. Cancer, 54 (1993) 765–771.CrossRefGoogle Scholar
  63. 63.
    Gaffey M, Mills S, and Lack E. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am. J. Surg. Pathol., 14 (1990) 1010–1023.PubMedCrossRefGoogle Scholar
  64. 64.
    Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J. Clin. Pathol., 34 (1981) 509–513.PubMedCrossRefGoogle Scholar
  65. 65.
    Böttger TC, Potratz D, Stöckle M, et al. Prognostic value of DNA analysis in colorectal carcinoma. Cancer, 72 (1993) 3579–3587.PubMedCrossRefGoogle Scholar
  66. 66.
    Fisher E, Sass R, Palekar A, et al. Dukes’ classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects. Cancer, 64 (1989) 2354–2360.PubMedCrossRefGoogle Scholar
  67. 67.
    Jessup JM, Lavin PT, Andrews CW, et al. Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis. Colon Rectum, 38 (1995) 1257–1264.PubMedCrossRefGoogle Scholar
  68. 68.
    Jessup J, McGinnis L, Steele G, et al. The National Cancer Data Base Report on Colon Cancer. Cancer, 78 (1996) 918–926.PubMedCrossRefGoogle Scholar
  69. 69.
    Ruschoff J, Bittinger A, Neumann K, et al. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol. Res. Pract., 186 (1990) 85–91.PubMedCrossRefGoogle Scholar
  70. 70.
    Scott NA, Wieand HS, Moertel CG, et al. Colorectal cancer. Dukes’ stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch. Surg., 122 (1987) 1375–1379.PubMedCrossRefGoogle Scholar
  71. 71.
    Wiggers T, Arends J, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis. Colon Rectum, 31 (1988) 33–41.PubMedCrossRefGoogle Scholar
  72. 72.
    Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch. Pathol. Lab. Med., 124 (2000) 979–994.PubMedGoogle Scholar
  73. 73.
    Steele G Jr, Mayer RJ, Podolsky DK, et al. Cancer of the colon, rectum, and anus. In Cancer Manual. 9th ed. Osteen RT (ed.). American Cancer Society, Farmington, MA, pp. 399–410.Google Scholar
  74. 74.
    Stower M and Hardcastle J. The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur. J. Surg. Oncol., 11 (1985) 119–123.PubMedGoogle Scholar
  75. 75.
    Sobin LH and Wittekind C (eds.). TNM Classification of Malignant Tumours: International Union Against Cancer. 5th ed. Wiley, New York, 1997.Google Scholar
  76. 76.
    Compton CC, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors consensus conference: Colorectal Working Group. Cancer, 88 (2000) 1739–1757.PubMedCrossRefGoogle Scholar
  77. 77.
    Shepherd N, Baxter K, and Love S. The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation. Gastroenterology, 112 (1997) 1096–1102.PubMedCrossRefGoogle Scholar
  78. 78.
    Tominaga T, Sakabe T, Koyama Y, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer, 78 (1996) 403–408.PubMedCrossRefGoogle Scholar
  79. 79.
    Zeng Z, Cohen AM, Hajdu S, et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer, 70 (1992) 737–740.PubMedCrossRefGoogle Scholar
  80. 80.
    Herrera-Omelas L, Justinian J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch. Surg., 122 (1987) 1253–1256.CrossRefGoogle Scholar
  81. 81.
    Scott KWM and Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br. J. Surg., 76 (1989) 1165–1167.PubMedCrossRefGoogle Scholar
  82. 82.
    Goldstein NS and Turner JR. Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas. Markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer, 88 (2000) 2228–2238.Google Scholar
  83. 83.
    Liefers G-J, Cleton-Jansen A-M, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med., 339 (1998) 223–228.PubMedCrossRefGoogle Scholar
  84. 84.
    Jeffers MD, O’Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J. Pathol., 172 (1994) 183–187.PubMedCrossRefGoogle Scholar
  85. 85.
    Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer, 86 (1999) 2668–2673.PubMedCrossRefGoogle Scholar
  86. 86.
    Cross SS, Bull AD, and Smith JHF. Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma? J. Clin. Pathol. 42 (1989) 1040–1042.PubMedCrossRefGoogle Scholar
  87. 87.
    Sloane JP, Ansell ID, Quirke P, and Underwood JCE. Standards and Minimum Datasets for Reporting Common Cancers. Minimum Dataset for Colorectal Cancer Histopathology Reports. The Royal College of Pathologists, London, UK, 1998.Google Scholar
  88. 88.
    Quirke P. Limitations of existing systems of staging for rectal cancer: the forgotten margin. In Rectal Cancer Research. Rajagopalan NT, ed. Springer-Verlag, New York, NY, 2001, pp. 63–81.Google Scholar
  89. 89.
    Adam IJ, Mohamdee MO, Martin IG, et al. Role of the circumferential margin involvement in the local recurrence of rectal cancer. Lancet, 344 (1994) 707–711.PubMedCrossRefGoogle Scholar
  90. 90.
    Chan K, Boey J, and Wong S. A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology, 9 (1985) 1319–1327.PubMedCrossRefGoogle Scholar
  91. 91.
    Quirke P and Scott N. The pathologist’s role in the assessment of local recurrence in rectal carcinoma. Surg. Oncol. Clin. N. Amer., 3 (1992) 1–17.Google Scholar
  92. 92.
    Quirke P, Durdy P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet, II (1986) 996–999.CrossRefGoogle Scholar
  93. 93.
    Knudsen JB, Nilsson T, Sprechler M, et al. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis. Colon Rectum, 26 (1983) 613–617.PubMedCrossRefGoogle Scholar
  94. 94.
    Horn A, Dahl O and Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis. Colon Rectum, 34 (1991) 798–804.PubMedCrossRefGoogle Scholar
  95. 95.
    Lee Y. Local and regional recurrence of carcinoma of the colon and rectum: I. Tumour-host factors and adjuvant therapy. Surg. Oncol., 4 (1995) 283–293.PubMedCrossRefGoogle Scholar
  96. 96.
    Talbot I, Ritchie S, Leighton MH, et al. The clinical significance of invasion of veins by rectal cancer. Br. J. Surg., 67 (1980) 439–442.PubMedCrossRefGoogle Scholar
  97. 97.
    Takahashi Y, Tucker S, Kitadai Y, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg., 132 (1997) 541–546.PubMedCrossRefGoogle Scholar
  98. 98.
    Minsky B, Mies C, Recht A, et al. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer, 61 (1988) 1417–1424.PubMedCrossRefGoogle Scholar
  99. 99.
    Minsky B, Mies C, Rich T, et al. Lymphatic vessel invasion in an independent prognostic factor for survival in colorectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 311–318.PubMedCrossRefGoogle Scholar
  100. 100.
    Ono M, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer, 78 (1996) 1179–1186.PubMedCrossRefGoogle Scholar
  101. 101.
    Sinicrope F, Hart J, Brasitus T, et al. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer, 74 (1994) 2908–2917.PubMedCrossRefGoogle Scholar
  102. 102.
    Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis. Colon Rectum, 36 (1993) 627–635.PubMedCrossRefGoogle Scholar
  103. 103.
    Thynne GS, Weiland LH, Moertel CG, et al. Correlation of histopathologic characteristics of primary tumor and uninvolved regional lymph nodes in Dukes’ C colonic carcinoma with prognosis. Mayo Clin. Proc., 55 (1980) 243–245.PubMedGoogle Scholar
  104. 104.
    Shirouzu K, Isomoto H, and Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer. Am. J. Surg., 165 (1993) 233–237.PubMedCrossRefGoogle Scholar
  105. 105.
    Pihl E, Malahy MA, Khankhanian N, et al. Immunomorphological features of prognostic significance in Dukes’ class B colorectal carcinoma. Cancer Res., 37 (1977) 4145–4149.PubMedGoogle Scholar
  106. 106.
    Svennevig JL, Lunde OC, Holter J, et al. Lymphoid infiltration and prognosis in colorectal carcinoma. Br. J. Cancer, 49 (1984) 375–377.PubMedCrossRefGoogle Scholar
  107. 107.
    Zhou XG, Yu BM, and Shen YX. Surgical treatment and late results in 1226 cases of colorectal cancer. Dis. Colon Rectum, 26 (1983) 250–256.PubMedCrossRefGoogle Scholar
  108. 108.
    Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut, 42 (1998) 673–679.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Carolyn C. Compton

There are no affiliations available

Personalised recommendations